1984-85 Resident in Medicine, Charles University School of Medicine
1994-96 Resident in Clinical Pathology, Department of Pathology, Brigham and Women's Hospital
1996-97 Clinical Fellow in Blood Banking/Transfusion Medicine, Brigham and Women's Hospital and Children's Hospital, Boston, MA

Certification:

American Board of Pathology (Clinical Pathology)
American Board of Pathology (Blood Banking/Transfusion Medicine)

Current Academic Appointment:

Associate Professor of Pathology, Harvard Medical School, Boston, MA

Current Medical Staff Appointment:

Director, Clinical Chemistry, Laboratory Control, and Ambulatory Care Center Clinical Laboratories

Selected Bibliography:

• Foxman EF, Jarolim P: Use of the fetal fibronectin test in decisions to admit to hospital for preterm labor. Clin Chem 2004; 50:663-665.
  
• Jarolim P, Kalabova D, Reid ME: Substitution Glu480Lys in erythroid band 3 corresponds to the Fra blood group antigen and supports existence of the second ectoplasmic loop of band 3. Transfusion 2004; 44:684-689.
  
• Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR: Time of onset and magnitude of increase in levothyroxine requirements during pregnancy in women with hypothyroidism. New Engl J Med 2004, 351:241-249.
  
• Gallagher PG, Jarolim P: Red blood cell membrane disorders. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P, eds. Hematology: Basic principles and practice, 4th edition, Philadelphia: Elsevier, 2005:669-691.
  
• Haspel RL, Jarolim P: The “cutting” edge: von Willebrand factor-cleaving protease activity in thrombotic microangiopathies. Transfusion and Apheresis Science 2005;32:177-184
  
• Morrow DA, de Lemos JA, Blazing MA, Sabatine MS, Murphy SA, Jarolim P, White HD, Fox KA, Califf RM, Braunwald E, for the A to Z Investigators: Prognostic value of B-type natriuretic peptide during follow-up of patients with unstable coronary artery disease in the A to Z Trial. J Amer Med Assoc 2005; 294:2866-2871.
  
• Zachlederova M, Jarolim P: The dynamics of gene expression in human lung microvascular endothelial cells after stimulation with inflammatory cytokines. Physiol Res 2006; 54:39-48.
  
• Scirica BM, Morrow DA, Cannon CP, Ray KK, Sabatine MS, Jarolim P, Shui A, McCabe CH, Braunwald E: Intensive Statin Therapy and the Risk of Heart Failure after an Acute Coronary Syndrome. J Am Coll Cardiol 2006; 47:2326-31.
  
• Cai YH, Alvarez A, Lim Y-C, Jarolim P, Lowe JB, Luscinskas FW, Lichtman AH: Abrogation of functional selectin-ligand expression reduces migration of pathogenic CD8+ T cells into heart. J Immunol 2006; 176:6568-75.
  
• Taqueti VR, Grabie N, Colvin R, Pang H, Jarolim P, Luster A, Glimcher L, Lichtman AH. T-bet controls pathogenicity of cytotoxic T lymphocytes in the heart by separable effects on migration and effector activity. J Immunol 2006; 177:5890-5901.
  
• Melanson SEF, Berg A, Jarolim P, Tanasijevic MJ, McElrath TF: Validation of a formula that calculates the estimated risk of respiratory distress syndrome. Obstet Gynecol 2006; 108:1471-1476.
  
• Karmpaliotis D, Ruisi CP, Kirtane AJ, MD, Polonsky T, Jarolim P, Malhotra A, Talmor D, Kosmidou I, Gibson CM, Morrow DA: Brain natriuretic peptide (BNP) in the diagnosis of cardiogenic versus noncardiogenic pulmonary edema in patients with hypoxic respiratory failure. Chest 2007; 131:964-971
  
• Collard CD, Shernan SK, Fox AK, Vaughn WK, Bernig T, Chanock SJ, Takahashi K, Ezekowitz AB, Jarolim P, Body SC: The MBL2 “LYQA Secretor” Haplotype is an Independent Predictor of Postoperative Myocardial Infarction in Caucasians Undergoing Coronary Artery Bypass Graft Surgery. Circulation 2007, in press.
  
• Melanson SEF, Morrow DA, Jarolim P: Earlier Detection of Myocardial Injury in a Preliminary Evaluation Using a New Troponin I Assay with Improved Sensitivity. Am J Clin Pathol 2007, in press.
  
• Blaha M, Cermanova M, Blaha V, Jarolim P, Andrys C, Blazek M, Maly J, Smolej L, Zajic J, Masin V, Zimova R, Rehacek V. Elevated serum soluble endoglin (sCD105) decreases during extracorporeal elimination therapy for familial hypercholesterolemia. Atherosclerosis. <javascript:AL_get(this, 'jour', 'Atherosclerosis.');> 2007 May 29; [Epub ahead of print]
  
• de Lemos JA, Morrow DA, Blazing MA, Jarolim P, Wiviott SD, Sabatine MS, Califf RM, Braunwald E: Serial Measurement of Monocyte Chemoattractant Protein-1 Following Acute Coronary Syndromes: Results from the A to Z Trial. J Am Coll Cardiol 2007, in press.
  
• Melanson, SEF, Lindeman N, Jarolim P: Selecting Automation for the Clinical Chemistry Laboratory. Arch Pathol Lab Med 2007, in press.
  
• Melanson, SEF, Tanasijevic MJ, Jarolim P: Cardiac Troponin Assays: A view from the clinical chemistry laboratory. Circulation 2007, in press.